Chairman and CEO Dr. Christopher Schaber joined IBN's BioMedWire Podcast to discuss the company's two-pronged business ...

The BioMedWire Podcast delivers dynamic interviews with industry experts at the forefront of pharmaceutical and biotech ...

Chairman and CEO Dr. Christopher Schaber joined IBN’s BioMedWire Podcast to discuss the company’s two-pronged business model, robust late-stage pipeline, and ongoing clinical trials. Schaber ...

Researchers at the Manchester Institute of Biotechnology (MIB) have demonstrated how genetically engineered enzymes can ...

Northwestern Medicine investigators have developed first-of-its-kind eyedrops that use synthetic nanoparticles to help the ...